Using an innovative combination of quality-by-design and green analytical chemistry approaches for the development of a stability indicating UHPLC method in pharmaceutical products

被引:43
|
作者
Bousses, Christine [1 ]
Ferey, Ludivine [2 ]
Vedrines, Elodie [1 ]
Gaudin, Karen [2 ]
机构
[1] Unither Developpement, Analyt Innovat, F-33185 Le Haillan, France
[2] Bordeaux Univ, EA Analyt & Pharmaceut Dev Appl Neglected Dis & C, F-33076 Bordeaux, France
关键词
Quality-by-design; Green chemistry; Experimental designs; Robustness; Accuracy profile; Dextromethorphan; ENVIRONMENTAL ASSESSMENT; CHROMATOGRAPHY; PRINCIPLES; DEXTROMETHORPHAN; PSEUDOEPHEDRINE; ELECTROPHORESIS; PARACETAMOL; SEPARATION; OPTIMIZE;
D O I
10.1016/j.jpba.2015.07.003
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
An innovative combination of green chemistry and quality by design (QbD) approach is presented through the development of an UHPLC method for the analysis of the main degradation products of dextromethorphan hydrobromide. QbD strategy was integrated to the field of green analytical chemistry to improve method understanding while assuring quality and minimizing environmental impacts, and analyst exposure. This analytical method was thoroughly evaluated by applying risk assessment and multivariate analysis tools. After a scouting phase aimed at selecting a suitable stationary phase and an organic solvent in accordance with green chemistry principles, quality risk assessment tools were applied to determine the critical process parameters (CPPs). The effects of the CPPs on critical quality attributes (CQAs), i.e., resolutions, efficiencies, and solvent consumption were further evaluated by means of a screening design. A response surface methodology was then carried out to model CQAs as function of the selected CPPs and the optimal separation conditions were determined through a desirability analysis. Resulting contour plots enabled to establish the design space (DS) (method operable design region) where all CQAs fulfilled the requirements. An experimental validation of the DS proved that quality within the DS was guaranteed; therefore no more robustness study was required before the validation. Finally, this UHPLC method was validated using the concept of total error and was used to analyze a pharmaceutical drug product. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:114 / 122
页数:9
相关论文
共 50 条
  • [1] Using an innovative Quality-by-Design approach for development of a stability indicating UHPLC method for ebastine in the API and pharmaceutical formulations
    Schmidt, Alexander H.
    Molnar, Imre
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2013, 78-79 : 65 - 74
  • [2] Implementation of analytical quality-by-design and green analytical chemistry approaches for the development of robust and ecofriendly UHPLC analytical method for quantification of chrysin
    Sharma, Teenu
    Jain, Atul
    Saini, Sumant
    Katare, O. P.
    Singh, Bhupinder
    SEPARATION SCIENCE PLUS, 2020, 3 (09) : 384 - 398
  • [3] UHPLC method for multiproduct pharmaceutical analysis by Quality-by-Design
    Ferey, Ludivine
    Raimbault, Adrien
    Rivals, Isabelle
    Gaudin, Karen
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2018, 148 : 361 - 368
  • [4] Quality-by-Design Based Development and Validation of Stability Indicating Method by UPLC Method for Impurities of Simvastatin from Drug and Pharmaceutical Dosage Form
    Desai, M. M.
    Nikalje, Ann Apratima G.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 83 (01) : 110 - 119
  • [5] Using an innovative quality-by-design approach for the development of a stability-indicating UPLC/Q-TOF-ESI-MS/MS method for stressed degradation products of imatinib mesylate
    Ren, Zhihui
    Zhang, Xiaoxi
    Wang, Haiyuan
    Jin, Xinghua
    RSC ADVANCES, 2016, 6 (16) : 13050 - 13062
  • [6] Stability Indicating Method Development and Validation of Teneligliptin by UHPLC Method in Bulk and Pharmaceutical Form
    Godase, Sameer Narayan
    Vikhe, Kavita Bhushan
    Kolhe, Mahesh Hari
    Mhaske, Shubham Balasaheb
    Bhor, Rohit Jaysing
    Gawali, Payal Sopan
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2024, 14 (02) : 585 - 592
  • [7] QbD green analytical procedure for the quantification of tolvaptan by utilizing stability indicating UHPLC method
    Hashmi, Shadab Anwar
    Alegete, Pallavi
    BMC CHEMISTRY, 2024, 18 (01)
  • [8] Analytical Quality By Design For Development Of A Sensitive, Rapid And Stability Indicating Method For Estimation Of Impurities Of Dimenhydrinate In Its Pharmaceutical Formulationl
    Girish, B. V.
    Praveen, S.
    Kathyayini, N.
    RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES, 2016, 7 (04): : 1309 - 1322
  • [9] Comprehensive stability-indicating method development of Avanafil Phosphodiesterase type 5 inhibitor using advanced Quality-by-Design approach
    Mital Patel
    Charmy Kothari
    Journal of Analytical Science and Technology, 11
  • [10] Comprehensive stability-indicating method development of Avanafil Phosphodiesterase type 5 inhibitor using advanced Quality-by-Design approach
    Patel, Mital
    Kothari, Charmy
    JOURNAL OF ANALYTICAL SCIENCE AND TECHNOLOGY, 2020, 11 (01)